- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Delisting of ProstaLund AB from Nasdaq First North Growth Market | 41 | GlobeNewswire | ProstaLund AB has applied for its shares to be delisted from Nasdaq First North Growth Market.
Nasdaq Stockholm AB has approved the application and decided to delist the shares of ProstaLund... ► Artikel lesen | |
| 12.09. | ProstaLund AB: ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman | 139 | GlobeNewswire (Europe) | ProstaLund has signed a collaboration agreement with the XEN Group, a prominent distributor of advanced innovative products with solid experience and contacts in the UAE and Oman. Through this partnership... ► Artikel lesen | |
| 10.09. | ProstaLund AB: ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market | 93 | GlobeNewswire (Europe) | ProstaLund has entered into a collaboration agreement with Mayumana Healthcare, a leading distributor of innovative urological solutions with strong expertise in the Benelux market. The partnership... ► Artikel lesen | |
| 21.08. | ProstaLund AB: ProstaLund AB - Interim Report January-June 2025 | 95 | GlobeNewswire (Europe) | April 1 - June 30Net sales reached MSEK 2.1 (2.8)Operating profit/loss totaled MSEK -6.3 (-7.2)Loss after taxes MSEK -6.5 (-7.1)Earnings per share, before and after dilution amounted to SEK -1.80 (-3.72)Cash... ► Artikel lesen | |
| 11.07. | The observation status for ProstaLund AB is updated | 224 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
Today... ► Artikel lesen | |
| 01.07. | The observation status for ProstaLund AB is updated | 175 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On May... ► Artikel lesen | |
| PROSTALUND Aktie jetzt für 0€ handeln | |||||
| 30.05. | ProstaLund AB: ProstaLund AB - Interim report January-March 2025 | 162 | GlobeNewswire (Europe) | Januari 1 - March 31Net sales reached SEK 3,7 million (3,5)Operating result amounted to -5,0 MSEK (-4,7)Profit after tax amounted to -5,0 MSEK (-4,8)Earnings per share before and after dilution amounted... ► Artikel lesen | |
| 23.05. | XFRA 7PL0: WIEDERAUFNAHME/RESUMPTION | 372 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 23.05. | The observation status for ProstaLund AB is updated | 253 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On May... ► Artikel lesen | |
| 21.05. | Lift of Suspension in ProstaLund AB at FNSE | 261 | GlobeNewswire | 2025-05-21T15:00:36Z
Lifting of Suspension
At Trading Venue FNSE
Ended on:
2025-05-21T14:50:00Z
Ongoing: False
Comments: Nasdaq Stockholm has, to the
extent applicable, also decided to lift the suspension... ► Artikel lesen | |
| 20.05. | ProstaLund AB: First patients treated with CoreTherm Eagle | 237 | GlobeNewswire (Europe) | The first patients with benign prostatic hyperplasia have been successfully treated using our new CoreTherm® Eagle platform.
"We are very pleased that the first patients have been successfully treated... ► Artikel lesen | |
| 19.05. | XFRA 7PL0: AUSSETZUNG/SUSPENSION | 170 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROSTALUND AB 7PL0... ► Artikel lesen | |
| 19.05. | Suspension of Trading in ProstaLund AB at FNSE | 226 | GlobeNewswire | 2025-05-19T07:01:39Z
Suspension
At Trading Venue FNSE
Due to Other
Ongoing:
True
Comments: Nasdaq Stockholm has, to the extent applicable, also decided to
suspend the trading in all other instruments... ► Artikel lesen | |
| 20.02. | ProstaLund AB: ProstaLund AB - Year-end report 2024 | 152 | GlobeNewswire (Europe) | "With several ongoing contract discussions for CoreTherm® Eagle, we are positive about the interest in our treatment and the upcoming international launch"
Fourth quarterOctober 1 - December 31Net sales... ► Artikel lesen | |
| 14.02. | ProstaLund AB: New study confirms the strong efficacy of CoreTherm in patients with large prostates | 243 | GlobeNewswire (Europe) | A newly published Danish study has evaluated the efficacy and safety of CoreTherm® in men with prostate sizes exceeding 100 grams. The median prostate size among participants was 126 g (range: 101-230... ► Artikel lesen | |
| 23.12.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.12.2024 | 560 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.12.2024
Aktien
1 US67090S1087 Nuveen Churchill Direct... ► Artikel lesen | |
| 20.12.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.12.2024 | 480 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.12.2024ISIN NameBMG1961Q3325 CATCO... ► Artikel lesen | |
| 20.12.24 | XFRA ISIN CHANGE | 375 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenSE0002372318 ProstaLund AB 20.12.2024 SE0023468418 ProstaLund AB 23.12.2024 Tausch 40:1 ► Artikel lesen | |
| 20.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.12.2024 | 535 | Xetra Newsboard | Das Instrument VSL AU000000DCC9 DIGITALX LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 20.12.2024 und ex Kapitalmassnahme am 23.12.2024 The instrument VSL AU000000DCC9 DIGITALX LTD. EQUITY is traded... ► Artikel lesen | |
| 18.12.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for ProstaLund AB | 234 | GlobeNewswire | Referring to the press release from ProstaLund AB's from December 17, the company will carry out a reverse stock split in relations 1:40. The share will be traded under new ISIN code with effect... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,540 | -2,10 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius nach einem Gespräch mit Konzernchef Michael Sen auf "Overweight" mit einem Kursziel von 49,10 Euro belassen. Am interessantesten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,040 | -2,04 % | Fresenius Medical Care: Shortseller ziehen sich zurück -Anleger auf dem Vormarsch | Fresenius Medical Care zeigt Stärke: Der Hedgefonds Marshall Wace hat seine Shortposition gesenkt - ein klares Signal für nachlassenden Verkaufsdruck. Technisch ist die Aktie nun bis rund 49,15 EUR... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,120 | +1,51 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| OTTOBOCK | 65,65 | -1,13 % | EQS-DD: Ottobock SE & Co. KGaA: Prof. Hans Georg Näder, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.10.2025 / 10:39... ► Artikel lesen | |
| GERRESHEIMER | 27,340 | -0,58 % | EQS-News: Gerresheimer AG: Gewinnwarnung/Quartalsergebnis | EQS-News: Gerresheimer AG
/ Schlagwort(e): Gewinnwarnung/Quartalsergebnis
Gerresheimer: Geschäftsverlauf und schwächeres Marktwachstum erfordern Prognoseanpassung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 44,840 | -1,45 % | Carl Zeiss Meditec-Aktie // Hoffnungsschimmer | In den vergangenen Monaten ging es mit der Carl Zeiss Meditec-Aktie kontinuierlich nach unten. Es bildet sich ein klassischer Abwärtstrend, dessen Ende nun kommen könnte. Allerdings lieferten auch die... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 30,770 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,315 | +0,29 % | Alignment Healthcare USA, LLC: Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors | ||
| ECKERT & ZIEGLER | 17,010 | -0,35 % | Eckert & Ziegler-Aktie vor Kursfeuerwerk: Insider greifen massiv zu - Jetzt dringend handeln! | ||
| LIFEMD | 6,430 | 0,00 % | LifeMD, Inc.: LifeMD Offers Ozempic at $499 Per Month through Collaboration with Novo Nordisk | NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk... ► Artikel lesen | |
| GOODRX | 4,015 | 0,00 % | ClearBridge Small Cap Strategy adds KWR, RNA, exits SEAT, GDRX among Q3 moves | ||
| GENEDX | 116,80 | 0,00 % | Illumina's constellation tech shows promise in GeneDx rare disease study | ||
| KINDLY MD | 0,798 | 0,00 % | KindlyMD, Inc: KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility | First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasury Financing Structure SALT LAKE CITY, UTAH / ACCESS Newswire / October... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,250 | +1,77 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 33,760 | 0,00 % | Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock |
PROSTALUND AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,002 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROSTALUND AB finden Sie auf Wallstreet Online.